##### Table of Contents

---

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549



---

Form 10-Q



---



|x | Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
|- | ---------------------------------------------------------------------------------------

For the quarterly period ended March 31, 2007

or



| ̈ | Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
|- | ----------------------------------------------------------------------------------------

For the transition period from  to

Commission file number: 000-30883



---

I-MANY, INC.

(Exact name of registrant as specified in its charter)



---



|                                                               |  |                                        
|-------------------------------------------------------------- |  | ---------------------------------------
|Delaware                                                       |  | 01-0524931                             
|(State or other jurisdiction of incorporation or organization) |  | (I.R.S. Employer Identification Number)

399 Thornall Street

12th Floor

Edison, New Jersey 08837

(Address of principal executive offices)

(800) 832-0228

(Registrants telephone number, including area code)



---

Indicate by check mark whether the registrant
(1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and
(2) has been subject to such filing requirements for the past 90 days.    Yes  x    No ̈

Indicate by check mark whether the registrant is a large accelerated filer, an
accelerated filer or a non-accelerated filer. See definition of accelerated filer and large accelerated filer in Rule 12b-2 of the Exchange Act.

Large Accelerated Filer ̈Accelerated Filer  x    Non-Accelerated Filer ̈

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes ̈No  x

On May 4, 2007, 51,949,399 shares of the registrants common stock, $.0001 par value, were issued and outstanding.



---



---

##### Table of Contents

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q contains forward-looking statements that involve risks and uncertainties. Discussions containing forward-looking
statements may be found in the information set forth in Part II, Item 1A, Risk Factors, of this Quarterly Report on Form 10-Q, as well as generally in this Form 10-Q. The Company uses words such as believes,
intends, expects, anticipates, plans, estimates, should, may, will, scheduled and similar expressions to identify forward-looking statements.
The Company uses these words to describe its present belief about future events relating to, among other things, its expected marketing plans, future hiring, expenditures and sources of revenue. This Form 10-Q may also contain third party estimates
regarding the size and growth of our market, which also are forward-looking statements. Our forward-looking statements apply only as of the date of this Form 10-Q. The Companys actual results could differ materially from those anticipated in
the forward-looking statements for many reasons, including the risks described above and elsewhere in this Form 10-Q.

Although the Company
believes that the expectations reflected in the forward-looking statements are reasonable, the Company cannot guarantee future results, levels of activity, performance or achievements. The Company is under no duty to update any of the
forward-looking statements after the date of this Form 10-Q to conform these statements to actual results or to changes in our expectations, other than as required by law.



2



---

##### Table of Contents

I-MANY, INC.

FORM 10-Q

TABLE OF CONTENTS



|         |  |                                                                                                    |  |    |  |     
|-------- |  | -------------------------------------------------------------------------------------------------- |  | -- |  | ----
|         |  |                                                                                                    |  |    |  | PAGE
|PART I.  |  | UNAUDITED FINANCIAL INFORMATION                                                                    |  |   
|         |  |                                                                                                   
|Item 1.  |  | Condensed Consolidated Financial Statements                                                        |  |   
|         |  |                                                                                                   
|         |  | Condensed Consolidated Balance Sheets as of March 31, 2007 and December 31, 2006                   |  | 4 
|         |  |                                                                                                   
|         |  | Condensed Consolidated Statements of Operations for the three months ended March 31, 2007 and 2006 |  | 5 
|         |  |                                                                                                   
|         |  | Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2007 and 2006 |  | 6 
|         |  |                                                                                                   
|         |  | Notes to Condensed Consolidated Financial Statements                                               |  | 7 
|         |  |                                                                                                   
|Item 2.  |  | Managements Discussion and Analysis of Financial Condition and Results of Operations              |  | 15
|         |  |                                                                                                   
|Item 3.  |  | Quantitative and Qualitative Disclosures About Market Risk                                         |  | 26
|         |  |                                                                                                   
|Item 4.  |  | Controls and Procedures                                                                            |  | 27
|         |  |                                                                                                   
|PART II. |  | OTHER INFORMATION                                                                                  |  |   
|         |  |                                                                                                   
|Item 1A  |  | Risk Factors                                                                                       |  | 27
|         |  |                                                                                                   
|Item 2.  |  | Unregistered Sales of Equity Securities and Use of Proceeds                                        |  | 30
|         |  |                                                                                                   
|Item 6.  |  | Exhibits                                                                                           |  | 30
|         |  |                                                                                                   
|         |  | Signatures                                                                                         |  | 31
|         |  |                                                                                                   
|         |  | Index to Exhibits                                                                                  |  | 32



3



---

##### Table of Contents

PART I. UNAUDITED FINANCIAL INFORMATION



|ITEM 1. | UNAUDITED FINANCIAL STATEMENTS
|------- | ------------------------------

I-MANY, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except share-related amounts)



|                                                                                                                |  |               |          |   |                  |   |          |  
|--------------------------------------------------------------------------------------------------------------- |  | ------------- | -------- | - | ---------------- | - | -------- | -
|                                                                                                                |  | March 31,2007 |          |   | December 31,2006 |  
|ASSETS                                                                                                          |  |               |          |   |                  |   |          |  
|Current assets:                                                                                                 |  |               |          |   |                  |   |          |  
|Cash and cash equivalents                                                                                       |  | $             | 15,227   |   |                  | $ | 17,232   |  
|Restricted cash                                                                                                 |  |               | 80       |   |                  |   | 80       |  
|Accounts receivable, net of allowance                                                                           |  |               | 6,913    |   |                  |   | 8,120    |  
|Prepaid expenses and other current assets                                                                       |  |               | 928      |   |                  |   | 766      |  
|                                                                                                                |  |               |          |   |                  |   |          |  
|Total current assets                                                                                            |  |               | 23,148   |   |                  |   | 26,198   |  
|Property and equipment, net                                                                                     |  |               | 1,394    |   |                  |   | 1,341    |  
|Restricted cash                                                                                                 |  |               | 428      |   |                  |   | 427      |  
|Other assets                                                                                                    |  |               | 127      |   |                  |   | 121      |  
|Acquired intangible assets, net                                                                                 |  |               | 185      |   |                  |   | 231      |  
|Goodwill                                                                                                        |  |               | 8,667    |   |                  |   | 8,667    |  
|                                                                                                                |  |               |          |   |                  |   |          |  
|Total assets                                                                                                    |  | $             | 33,949   |   |                  | $ | 36,985   |  
|                                                                                                                |  |               |          |   |                  |   |          |  
|LIABILITIES, REDEEMABLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY                                                |  |               |          |   |                  |   |          |  
|Current liabilities:                                                                                            |  |               |          |   |                  |   |          |  
|Accounts payable                                                                                                |  | $             | 2,835    |   |                  | $ | 2,549    |  
|Accrued expenses                                                                                                |  |               | 4,715    |   |                  |   | 4,675    |  
|Current portion of deferred revenue                                                                             |  |               | 16,518   |   |                  |   | 15,773   |  
|Current portion of capital lease obligations                                                                    |  |               | 193      |   |                  |   | 154      |  
|                                                                                                                |  |               |          |   |                  |   |          |  
|Total current liabilities                                                                                       |  |               | 24,261   |   |                  |   | 23,151   |  
|Deferred revenue, net of current portion                                                                        |  |               | 1,004    |   |                  |   | 1,256    |  
|Capital lease obligations, net of current portion                                                               |  |               | 265      |   |                  |   | 240      |  
|Other long-term liabilities                                                                                     |  |               | 882      |   |                  |   | 884      |  
|                                                                                                                |  |               |          |   |                  |   |          |  
|Total liabilities                                                                                               |  |               | 26,412   |   |                  |   | 25,531   |  
|                                                                                                                |  |               |          |   |                  |   |          |  
|Series A redeemable convertible preferred stock, $.01 value                                                     |  |               |         |   |                  |   |         |  
|Authorized  1,700 shares                                                                                       |  |               |          |   |                  |   |          |  
|Issued and outstanding  none                                                                                   |  |               |          |   |                  |   |          |  
|                                                                                                                |  |              
|Stockholders equity:                                                                                           |  |               |          |   |                  |   |          |  
|Undesignated preferred stock, $.01 par value                                                                    |  |               |          |   |                  |   |          |  
|Authorized5,000,000 shares; designated 1,700 shares                                                            |  |               |          |   |                  |   |          |  
|Issued and outstandingnone                                                                                     |  |               |         |   |                  |   |         |  
|Common stock, $.0001 par value                                                                                 |  |               |          |   |                  |   |          |  
|Authorized100,000,000 shares                                                                                   |  |               |          |   |                  |   |          |  
|Issued and outstanding  51,925,754 and 51,718,992 shares at March 31, 2007 and December 31, 2006, respectively |  |               | 5        |   |                  |   | 5        |  
|Additional paid-in capital                                                                                      |  |               | 162,296  |   |                  |   | 161,690  |  
|Accumulated other comprehensive loss                                                                            |  |               | (7       | ) |                  |   | (6       | )
|Accumulated deficit                                                                                             |  |               | (154,757 | ) |                  |   | (150,235 | )
|                                                                                                                |  |               |          |   |                  |   |          |  
|Total stockholders' equity                                                                                      |  |               | 7,537    |   |                  |   | 11,454   |  
|                                                                                                                |  |               |          |   |                  |   |          |  
|Total liabilities and stockholders' equity                                                                      |  | $             | 33,949   |   |                  | $ | 36,985   |  
|                                                                                                                |  |               |          |   |                  |   |          |  

See notes to condensed consolidated financial statements.



4



---

##### Table of Contents

I-MANY, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share amounts)



|                                            |  |                              |        |   |      |   |        |  
|------------------------------------------- |  | ---------------------------- | ------ | - | ---- | - | ------ | -
|                                            |  | Three months ended March 31, |       
|                                            |  | 2007                         |        |   | 2006 |  
|Net revenues:                               |  |                              |        |   |      |   |        |  
|Recurring                                   |  | $                            | 4,425  |   |      | $ | 3,780  |  
|Services                                    |  |                              | 2,988  |   |      |   | 2,749  |  
|License                                     |  |                              | 940    |   |      |   | 1,089  |  
|                                            |  |                              |        |   |      |   |        |  
|Total net revenues                          |  |                              | 8,353  |   |      |   | 7,618  |  
|                                            |  |                             
|Operating expenses:                         |  |                              |        |   |      |   |        |  
|Cost of recurring revenue                   |  |                              | 1,651  |   |      |   | 1,447  |  
|Cost of services revenue                    |  |                              | 2,956  |   |      |   | 2,370  |  
|Cost of third-party technology              |  |                              | 76     |   |      |   | 77     |  
|Amortization of acquired intangible assets  |  |                              | 46     |   |      |   | 343    |  
|Sales and marketing                         |  |                              | 2,315  |   |      |   | 2,073  |  
|Research and development                    |  |                              | 4,304  |   |      |   | 2,978  |  
|General and administrative                  |  |                              | 1,452  |   |      |   | 1,313  |  
|Depreciation                                |  |                              | 188    |   |      |   | 171    |  
|Restructuring and other charges (credits)   |  |                              | 62     |   |      |   | 8      |  
|                                            |  |                              |        |   |      |   |        |  
|Total operating expenses                    |  |                              | 13,050 |   |      |   | 10,780 |  
|                                            |  |                              |        |   |      |   |        |  
|Loss from operations                        |  |                              | (4,697 | ) |      |   | (3,162 | )
|                                            |  |                             
|Other income, net                           |  |                              | 175    |   |      |   | 132    |  
|                                            |  |                              |        |   |      |   |        |  
|Net loss                                    |  | $                            | (4,522 | ) |      | $ | (3,030 | )
|                                            |  |                              |        |   |      |   |        |  
|Basic and diluted net loss per common share |  | $                            | (0.09  | ) |      | $ | (0.06  | )
|                                            |  |                              |        |   |      |   |        |  
|Weighted average shares outstanding         |  |                              | 51,465 |   |      |   | 46,676 |  
|                                            |  |                              |        |   |      |   |        |  

See notes to condensed consolidated financial statements.



5



---

##### Table of Contents

I-MANY, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)



|                                                                            |  |                             |        |   |      |   |        |  
|--------------------------------------------------------------------------- |  | --------------------------- | ------ | - | ---- | - | ------ | -
|                                                                            |  | Three Months EndedMarch 31, |       
|                                                                            |  | 2007                        |        |   | 2006 |  
|Cash Flows from Operating Activities:                                       |  |                             |        |   |      |   |        |  
|Net loss                                                                    |  | $                           | (4,522 | ) |      | $ | (3,030 | )
|Adjustments to reconcile net loss to net cash used in operating activities: |  |                             |        |   |      |   |        |  
|Depreciation and amortization                                               |  |                             | 234    |   |      |   | 514    |  
|Restructuring and other charges                                             |  |                             | 62     |   |      |   | 8      |  
|Amortization of deferred stock-based compensation                           |  |                             | 553    |   |      |   | 257    |  
|Changes in operating assets and liabilities, net of acquisitions:           |  |                             |        |   |      |   |        |  
|Restricted cash                                                             |  |                             | (1     | ) |      |   | (2     | )
|Accounts receivable                                                         |  |                             | 1,207  |   |      |   | 2,412  |  
|Prepaid expense and other current assets                                    |  |                             | (162   | ) |      |   | (176   | )
|Accounts payable                                                            |  |                             | 286    |   |      |   | 66     |  
|Accrued expenses and other liabilities                                      |  |                             | (30    | ) |      |   | (601   | )
|Deferred revenue                                                            |  |                             | 493    |   |      |   | 797    |  
|Deferred rent                                                               |  |                             | 5      |   |      |   | (12    | )
|Other assets                                                                |  |                             | (6     | ) |      |   | (4     | )
|                                                                            |  |                             |        |   |      |   |        |  
|Net cash provided by (used in) operating activities                         |  |                             | (1,881 | ) |      |   | 229    |  
|                                                                            |  |                             |        |   |      |   |        |  
|Cash Flows from Investing Activities:                                       |  |                             |        |   |      |   |        |  
|Purchases of property and equipment                                         |  |                             | (127   | ) |      |   | (210   | )
|                                                                            |  |                             |        |   |      |   |        |  
|Net cash used in investing activities                                       |  |                             | (127   | ) |      |   | (210   | )
|                                                                            |  |                             |        |   |      |   |        |  
|Cash Flows from Financing Activities:                                       |  |                             |        |   |      |   |        |  
|Payments on capital lease obligations                                       |  |                             | (50    | ) |      |   | (1     | )
|Proceeds from exercise of stock options                                     |  |                             | 53     |   |      |   | 61     |  
|Proceeds from exercise of common stock warrant                              |  |                             |       |   |      |   | 300    |  
|                                                                            |  |                             |        |   |      |   |        |  
|Net cash provided by financing activities                                   |  |                             | 3      |   |      |   | 360    |  
|                                                                            |  |                             |        |   |      |   |        |  
|Net increase (decrease) in cash and cash equivalents                        |  |                             | (2,005 | ) |      |   | 379    |  
|Cash and cash equivalents, beginning of period                              |  |                             | 17,232 |   |      |   | 16,805 |  
|                                                                            |  |                             |        |   |      |   |        |  
|Cash and cash equivalents, end of period                                    |  | $                           | 15,227 |   |      | $ | 17,184 |  
|                                                                            |  |                             |        |   |      |   |        |  
|Supplemental disclosure of Cash Flow Information:                           |  |                             |        |   |      |   |        |  
|Cash paid during the period for interest                                    |  | $                           | 12     |   |      | $ |       |  
|                                                                            |  |                             |        |   |      |   |        |  
|Supplemental disclosure of Noncash Activities:                              |  |                             |        |   |      |   |        |  
|Property and equipment acquired under capital leases                        |  | $                           | 114    |   |      | $ |       |  
|                                                                            |  |                             |        |   |      |   |        |  

See notes to condensed consolidated financial statements.



6



---

##### Table of Contents

I-MANY, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

NOTE 1. BASIS OF PRESENTATION

The accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally
accepted in the United States of America applicable to interim financial reporting pursuant to the rules and regulations of the Securities and Exchange Commission (SEC) for reporting on Form 10-Q. It is recommended that these condensed
consolidated financial statements be read in conjunction with the financial statements and the related notes of I-many, Inc. (the Company) for the year ended December 31, 2006 as reported in the Companys Annual Report on Form
10-K filed with the SEC. In the opinion of management, all adjustments (consisting of normal, recurring adjustments) considered necessary for the fair presentation of these interim financial statements have been included. The results of operations
for the three months ended March 31, 2007 may not be indicative of the results that may be expected for the year ending December 31, 2007, or for any other period.

NOTE 2. SIGNIFICANT ACCOUNTING POLICIES

Revenue Recognition:

The Company recognizes revenue in accordance with Statement of Position (SOP) 97-2, Software Revenue Recognition, and SOP 98-9, Software
Revenue Recognition, with Respect to Certain Arrangements. Software license fees are recognized upon execution of a signed license agreement and delivery of the software to customers, provided there are no significant post-delivery
obligations, the payment is fixed or determinable and collection is probable. In multiple-element arrangements, a portion of the total fee is allocated to the undelivered professional services, training and maintenance and support services based on
the fair value of those elements, which is defined as the price charged when those elements are sold separately. The residual amount is then allocated to the software license fee. In cases where the Company agrees to deliver unspecified additional
products in the future, the license fee is recognized as subscription revenue ratably over the term of the arrangement beginning with the delivery of the first product. In cases where the Company agrees to deliver specified additional products or
upgrades in the future, recognition of the entire license fee, including any related maintenance and support fees, is deferred until after the specified additional products or upgrades are delivered and made generally available to all customers. If
an acceptance period is required, revenues are deferred until customer acceptance. In cases where collection is not deemed probable, we recognize the license fee as payments are received. In cases where significant production or customization is
required prior to attaining technological feasibility of the software, license fees are recognized on a percentage-of-completion basis and are credited to research and development expenses as a funded development arrangement. After the software
attains technological feasibility, recognizable license fees are reported as product revenue.

In 2007, the Company began to classify its
reported net revenues into three revenue categories  Recurring, Services and License revenues  after having previously reported its revenues as being either Product or Service. Recurring revenue consists of (i) fees generated from
the provision of maintenance, support, and hosting services and (ii) subscription revenues. Services revenue is now comprised of professional service and training fees and reimbursable out-of-pocket expenses. License revenue consists of
non-recurring license fees generated from perpetual license agreements.



7



---

##### Table of Contents

Current and prospective customers have the option of entering into a subscription agreement as an
alternative to the Companys standard perpetual license contract model. The standard subscription arrangement is presently a fixed fee agreement over three or more years, covering license fees, unspecified new product releases and maintenance
and support, generally payable in equal quarterly installments commencing upon execution of the agreement. In approximately half of the agreements that have been executed to date, the subscription arrangement converts free-of-charge to a perpetual
license after the completion of the initial term plus any extensions, generally after five years, after which time the customer would have the option of paying for the continuation of maintenance and support. Also included in subscription revenues
are license fees generated from perpetual license arrangements with rights to unspecified additional products, which are treated as subscriptions for accounting purposes. The Company recognizes all revenue from subscription-based arrangements
ratably over the term of the subscription agreement commencing upon delivery of the initial product. Subscription installment amounts that are not yet contractually billable to customers are not reflected in deferred revenues on the Companys
consolidated balance sheet.

Maintenance and support fees are recognized ratably over the term of the service period, which is generally
twelve months. When maintenance and support is included in the total license fee, a portion of the total fee is allocated to maintenance and support based upon the price paid by the customer when sold separately, generally as renewals in the second
year.

Professional service revenues are recognized as the services are performed. If conditions for acceptance exist, professional service
revenues are recognized upon customer acceptance. For fixed fee professional service contracts, anticipated losses are provided for in the period in which the loss is probable and can be reasonably estimated. Training revenues are recognized as the
services are provided. Included in training revenues are registration fees received from participants in the Companys off-site user training conferences.

Payments received from customers at the inception of a maintenance period are treated as deferred service revenues and recognized ratably over the maintenance period. Payments received from customers in advance of
product shipment or revenue recognition are treated as deferred revenues and recognized when the product is shipped to the customer or when otherwise earned.

During the third quarter of 2005, the Company became aware of certain defects in the current version of one of its software products, which was first shipped to customers in the fourth quarter of 2004. These defects,
which were not identified in pre-release product testing, affected the performance of the software for a portion of the Companys customers depending on each customers particular implementation environment and its intended use of the
software. Because certain concessions have been made to customers in connection with these defects, the Company has generally not recognized revenue from sales of this software product and related implementation services beginning in the third
quarter of 2005, except in those cases in which it was determined that the customer was not likely to be affected by the known, unresolved software defects. During 2006, new versions of the software were released, but problems continued to occur
with implementations at several customer sites. In the first quarter of 2007, the Company released a new version of the software which was designed to resolve known performance defects with minimal additional functionality. However, the Company
intends to continue deferring revenue in connection with license sales, maintenance and support, and implementation services for this software product until it has been demonstrated at multiple customer sites that the new release of the software is
free of significant performance defects. As of March 31, 2007 and December 31, 2006, the Company has reversed and deferred cumulative amounts of $4.0 million and $3.5 million, respectively, of otherwise-recognizable product and service
revenue, based in part on its estimate of the fair value of concessions to be made until the remaining defect is resolved, and partly on its determination that license fees were not fixed and determinable because of the possibility of future
concessions.



8



---

##### Table of Contents

Stock-based Compensation:

On January 1, 2006, the Company adopted Statement of Financial Accounting Standards (FAS) No. 123 (revised 2004) (FAS 123(R)), Share-based Payment. Under FAS 123(R), the
Company measures and records the compensation cost of employee and director services received in exchange for stock option grants and other equity awards based on the grant-date fair value of the awards. The values of the portions of the awards that
are ultimately expected to vest are recognized as expense over the requisite service periods. The Company accounts for stock options and awards granted to non-employees other than directors using the fair-value method.

Under the fair-value method, compensation associated with equity awards is determined based on the estimated fair value of the award itself, measured
using either current market data or an established option pricing model. The measurement date for employee and director awards is generally the date of grant. The measurement date for awards granted to non-employees other than directors is generally
the date that performance of certain services is complete.

The Company's estimates of the fair value of stock option grants were made
using the Black-Scholes option pricing model with the following assumptions and resulted in the following weighted average grant-date fair values of options granted during the three months ended March 31:



|                                                                            |  |           |  |          
|--------------------------------------------------------------------------- |  | --------- |  | ---------
|                                                                            |  | 2007      |  | 2006     
|Risk-free interest rates                                                    |  | 4.50%     |  | 4.86%    
|Dividend yield                                                              |  |          |  |         
|Expected volatility                                                         |  | 60%       |  | 70%      
|Expected term (in years)                                                    |  | 6.11-7.50 |  | 5.75-6.25
|Weighted average grant-date fair value of options granted during the period |  | $1.12     |  | $1.04    

The Company uses historical volatility of the Companys common stock to estimate expected volatility. The
expected term of options granted is estimated to be equal to the average of the contractual life of the options and the grants average vesting period. The risk-free interest rate is derived quarterly from the published US Treasury yield curve,
based on expected term, in effect as of the last day of the period.

The following table summarizes the components of stock-based
compensation expense for the three month periods ended March 31:



|                                                   |  |      |     |      |   |    
|-------------------------------------------------- |  | ---- | --- | ---- | - | ---
|(Amounts in thousands)                             |  | 2007 |     | 2006
|Stock option grants issued prior to 2006           |  | $    | 78  |      | $ | 170
|Stock option grants issued subsequent to 2005      |  |      | 333 |      |   | 10 
|Restricted stock grants to directors and employees |  |      | 128 |      |   | 61 
|Employee stock purchase plan                       |  |      | 14  |      |   | 16 
|                                                   |  |      |     |      |   |    
|Total stock-based compensation expense             |  | $    | 553 |      | $ | 257
|                                                   |  |      |     |      |   |    

As of March 31, 2007, unamortized compensation cost, net of estimated forfeitures, related to
nonvested stock options and nonvested restricted shares granted under the various stock incentive plans amounted to $3.9 million and $374,000, respectively. These costs are expected to be amortized over weighted average periods of 2.1 years and 0.9
years, respectively.



9



---

##### Table of Contents

The Company has four current stock incentive plans: (i) the 2000 Non-Employee Director Stock Option
Plan, which provides for the granting of annual (25,000-share) and new hire (62,500-share) non-qualified stock options to non-employee directors, (ii) the 2001 Employee Stock Option Plan, which provides for grants in the form of non-qualified
stock options, with not more than 25,000 shares to be issued in the aggregate to officers or directors of the Company, and (iii) the 2001 and 2003 Stock Incentive Plans, both of which are shareholder-approved plans and provide for the grant of
incentive stock options and other equity awards to the Companys employees, directors and consultants. The company also has an employee stock purchase plan that allows employees to purchase stock at a 15% discount to market prices subject to
certain limitations. Participation is optional and enrollment periods are every six months.

The following table summarizes total common
shares available for future grants of stock options and other equity awards at March 31, 2007:



|                                             |  |          
|-------------------------------------------- |  | ---------
|2000 Non-Employee Director Stock Option Plan |  | 162,500  
|2001 Employee Stock Option Plan              |  | 875,555  
|2001 Stock Incentive Plan                    |  | 11,480   
|2003 Stock Incentive Plan                    |  | 1,285,132
|                                             |  |          
|Total available for future grant             |  | 2,334,667
|                                             |  |          

Option awards are generally granted with an exercise price equal to the market price of the
Companys common stock at the date of grant. Stock options expire 10 years after grant and vest over periods set by the Board of Directors at the time of grant. Generally, option awards vest ratably over four years for employee grants and over
three years for grants to directors. Certain stock option awards provide for accelerated vesting if there is a change in control.

The
following table summarizes stock option activity under all of the Company's stock option plans for the three month period ended March 31, 2007:



|                                 |  |                  |   |  |                                 |       |                                         |           |                               |   |      
|-------------------------------- |  | ---------------- | - |  | ------------------------------- | ----- | --------------------------------------- | --------- | ----------------------------- | - | -----
|                                 |  | Number of Shares |   |  | Weighted Average Exercise Price |       | WeightedAverageRemainingContractualTerm |           | AggregateIntrinsicValue($000)
|Outstanding at December 31, 2006 |  | 7,176,757        |   |  | $                               | 2.002 |                                         |           |                               |   |      
|Granted                          |  | 841,000          |   |  |                                 | 1.784 |                                         |           |                               |   |      
|Exercised                        |  | (135,630         | ) |  |                                 | 0.395 |                                         |           |                               |   |      
|Canceled                         |  | (222,350         | ) |  |                                 | 1.723 |                                         |           |                               |   |      
|                                 |  |                  |   |  |                                 |       |                                         |           |                               |   |      
|Outstanding at March 31, 2007    |  | 7,659,777        |   |  | $                               | 2.015 |                                         | 8.0 years |                               | $ | 3,202
|                                 |  |                  |   |  |                                 |       |                                         |           |                               |   |      
|Exercisable at March 31, 2007    |  | 2,741,614        |   |  | $                               | 2.321 |                                         | 6.1 years |                               | $ | 2,430
|                                 |  |                  |   |  |                                 |       |                                         |           |                               |   |      

The total intrinsic value of stock options exercised during the three-month periods ended March 31, 2007 and
2006 was $201,000 and $204,000, respectively.

A summary of the status of the Companys nonvested restricted shares as of
March 31, 2007, and changes during the three months ended March 31, 2007, is presented below:



|                               |  |                  |   |  |                                        |      
|------------------------------ |  | ---------------- | - |  | -------------------------------------- | -----
|                               |  | Number of Shares |   |  | Weighted Average Grant-Date Fair Value
|Nonvested at December 31, 2006 |  | 332,770          |   |  | $                                      | 1.582
|Granted                        |  | 71,132           |   |  |                                        | 1.673
|Vested                         |  | (66,238          | ) |  |                                        | 1.431
|                               |  |                  |   |  |                                        |      
|Nonvested at March 31, 2007    |  | 337,664          |   |  | $                                      | 1.631
|                               |  |                  |   |  |                                        |      



10



---

##### Table of Contents

The total fair value of restricted shares which vested during the three months ended March 31, 2007 and 2006 was
$95,000 and $24,000, respectively.

Acquired Intangible Assets and Goodwill:

Acquired intangible assets (excluding goodwill) are amortized on a straight-line basis over their estimated useful lives and reviewed for impairment on an
annual basis, or on an interim basis if an event or circumstance occurs between annual tests indicating that the assets might be impaired. The impairment test consists of comparing the cash flows expected to be generated by the acquired intangible
asset to its carrying amount. If the asset is considered to be impaired, an impairment loss is recognized in an amount by which the carrying amount of the asset exceeds its fair value. Acquired intangible assets with indefinite useful lives will not
be amortized until their lives are determined to be definite.

Goodwill is tested for impairment using a two-step approach. The first step
is to compare the fair value of a reporting unit to its carrying amount, including goodwill. If the fair value of the reporting unit is greater than its carrying amount, goodwill is not considered impaired and the second step is not required. If the
fair value of the reporting unit is less than its carrying amount, the second step of the impairment test measures the amount of the impairment loss, if any, by comparing the implied fair value of goodwill to its carrying amount. If the carrying
amount of goodwill exceeds its implied fair value, an impairment loss is recognized equal to that excess. The implied fair value of goodwill is calculated in the same manner that goodwill is calculated in a business combination, whereby the fair
value of the reporting unit is allocated to all of the assets and liabilities of that unit (including any unrecognized intangible assets), with the excess purchase price over the amounts assigned to assets and liabilities representing
the implied fair value of goodwill. Goodwill is tested for impairment at least annually, or on an interim basis if an event occurs or circumstances change that would likely reduce the fair value of a reporting unit below its carrying value.

Income Taxes:

In June 2006, the
Financial Accounting Standards Board (FASB) issued Interpretation No. 48 (FIN 48) regarding Accounting for Uncertainties in Income Taxes, which defines the threshold for recognizing the benefits of tax-return
positions in the financial statements as more-likely-than-not to be sustained by the taxing authorities. FIN 48 also requires explicit disclosure requirements about a Companys uncertainties related to their income tax position,
including a detailed roll-forward of tax benefits taken that do not qualify for financial statement recognition. The Company adopted FIN 48 effective January 1, 2007 and its adoption did not have a material effect on the Companys
financial position, results of operations or cash flows.

The Company and its wholly-owned domestic subsidiaries are subject to U.S.
federal income tax as well as income tax of multiple state jurisdictions. To date, the Internal Revenue Service and most of the relevant state taxing authorities have not conducted examinations of any of the Companys U.S. and state income tax
returns since the Companys inception. The Companys wholly-owned subsidiary based in the United Kingdom is subject to income taxes imposed by the United Kingdom.



11



---

##### Table of Contents

The Companys practice is to recognize interest and/or penalties related to income tax matters in
income tax expense. To date, such interest and penalty charges have not been material.

A deferred tax asset or liability is recorded for
temporary differences in the bases of assets and liabilities for book and tax purposes and loss carry forwards based on enacted rates expected to be in effect when these temporary items are expected to reverse. Valuation allowances are provided to
the extent it is more likely than not that all or a portion of the deferred tax assets will not be realized.

Product Indemnification:

The Companys agreements with customers generally include certain provisions for indemnifying the customer against losses, expenses, and
liabilities from damages that may be awarded against the customer in the event that our products are found to infringe upon a patent, copyright, trademark, or other proprietary right of a third party. The agreements generally seek to limit the scope
of remedies for such indemnification obligations in a variety of industry-standard respects, including our right to replace an infringing product. To date, we have not had to reimburse any of our customers for any losses related to these
indemnification provisions and no claims were outstanding as of March 31, 2007 and December 31, 2006. We do not expect that any significant impact on financial position or the results of operations will result from these indemnification
provisions.

Reclassifications:

Beginning in 2007, the Company has revised its presentation of net revenues into three reportable categories: (i) Recurring revenue, which consists of fees generated from the provision of maintenance, support, and hosting services and
subscription revenues, (ii) Services revenue, which is comprised of professional service fees and reimbursable expenses, and (iii) License revenue, which consists of non-recurring license fees generated from perpetual license agreements.
Previously, net revenues were presented as either Product revenues, comprised of license and subscription fees, or Service revenues, comprised of revenues generated from professional services, maintenance and support, and hosting arrangements. Also,
in order for its various cost of revenues to be combined and presented in the same manner as its reported revenues, the Company has reclassified certain amounts previously included in Cost of services into the newly-created Cost of recurring
revenue. The related amounts in the 2006 Condensed Consolidated Statements of Operations have been reclassified to be consistent with the current year presentation.

New Accounting Pronouncements:

In September 2006, the FASB issued Statement of Financial Accounting
Standards ("SFAS") No. 157, "Fair Value Measurements" ("SFAS No. 157"), which defines fair value, establishes a framework for measuring fair value in generally accepted accounting principles, and expands disclosures about fair value
measurements. SFAS No. 157 applies under a number of other accounting pronouncements that require or permit fair value measurements. The provisions of SFAS No. 157 are effective for the Company beginning January 1, 2008. The Company
is currently evaluating the impact of adopting SFAS No. 157 on its financial position and results of operations.

NOTE 3. NET LOSS PER SHARE

Basic net loss per share was determined by dividing the net loss applicable to common stockholders by the weighted-average number of shares
of common stock outstanding during the period. Diluted net loss per share was the same as basic net loss per share for all periods



12



---

##### Table of Contents

presented since the effect of any potentially dilutive securities was excluded, as they are anti-dilutive as a result of the Companys net losses. The
total numbers of common equivalent shares excluded from the diluted loss per share calculation were 1,373,142 and 1,660,236, respectively, for the three months ended March 31, 2007 and 2006.

NOTE 4. SIGNIFICANT CUSTOMERS

The Company had certain
customers which individually generated revenues comprising a significant percentage of total revenue, as follows:



|           |  |                              |  |     
|---------- |  | ---------------------------- |  | ----
|           |  | Three months ended March 31,
|           |  | 2007                         |  | 2006
|Customer A |  | 17%                          |  | *   
|Customer B |  | *                            |  | 10% 

The Company had certain customers whose accounts receivable balances individually represented a
significant percentage of total receivables, as follows:



|           |  |           |  |     
|---------- |  | --------- |  | ----
|           |  | March 31,
|           |  | 2007      |  | 2006
|Customer A |  | 25%       |  | *   
|Customer C |  | 13%       |  | 11% 
|Customer D |  | *         |  | 15% 

---

|* | was less than 10% of the Companys total
|- | ----------------------------------------

NOTE 5. STRATEGIC
RELATIONSHIP AGREEMENT

In May 2000, the Company entered into a ten-year Strategic Relationship Agreement (the Initial P&G
Agreement) with The Procter & Gamble Company (P&G), pursuant to which P&G designated the Company as its exclusive provider of purchase contract management software for its commercial products group for a period of
three years. In addition, P&G has agreed to provide the Company with certain strategic marketing and business development services over the term of the P&G Agreement. P&G also entered into an agreement to license certain software and
technology from the Company.

As consideration for entering into the Initial P&G Agreement, the Company granted to P&G a fully
exercisable warrant to purchase 875,000 shares of common stock. The warrant did not require any future product purchases or service performance. The warrant, which was exercisable for a period of two years at an exercise price of $9.00 per
share, was converted into 561,960 shares of common stock via a non-cash exercise during 2000. In addition, the Company had agreed to pay P&G a royalty of up to 10% of the revenue generated from the commercial products market, as defined. As of
February 2003, no such royalties had been earned or paid.

In February 2003, the Initial P&G Agreement was amended to delete the
royalty provision, in exchange for which the Company granted to P&G a fully exercisable warrant to purchase 1,000,000 shares of the Companys common stock. The warrant was exercisable for a period of three years at an exercise price of
$1.20 per share. In November 2004, April 2005 and June 2005, P&G partially exercised the warrant, acquiring an aggregate of 750,000 shares of the Companys common stock. In February 2006, P&G exercised the remaining 250,000 shares
of the warrant.



13



---

##### Table of Contents

NOTE 6. SEGMENT DISCLOSURE

The Company measures operating results as two reportable segments, each of which provide multiple products and services that allow manufacturers, purchasers and intermediaries to manage their complex contracts for the
purchase and sale of goods. These segments are consistent with how management establishes strategic goals, allocates resources and evaluates performance. The accounting policies of the segments are the same as those described in the summary of
significant accounting policies. The Companys reportable segments are strategic business units that market to separate and distinct industry groups: (i) health and life sciences, which includes pharmaceutical manufacturers, and
(ii) industry solutions, which comprises all other industries. The following tables reflect the results of the segments consistent with the Companys management system.



|                                                  |  |                         |        |   |                   |   |        |              |  |   |        |   |  |   |        |  
|------------------------------------------------- |  | ----------------------- | ------ | - | ----------------- | - | ------ | ------------ |  | - | ------ | - |  | - | ------ | -
|(Amounts in thousands)                            |  | Health and LifeSciences |        |   | IndustrySolutions |   |        | Undesignated |  |   | Totals |  
|At and for the three months ended March 31, 2007: |  |                         |        |   |                   |   |        |              |  |   |        |   |  |   |        |  
|Revenues                                          |  | $                       | 6,383  |   |                   | $ | 1,970  |              |  | $ |       |   |  | $ | 8,353  |  
|Segment loss                                      |  |                         | (1,182 | ) |                   |   | (3,340 | )            |  |   |       |   |  |   | (4,522 | )
|Segment assets                                    |  |                         | 24,842 |   |                   |   | 3,156  |              |  |   | 5,951  |   |  |   | 33,949 |  
|Goodwill                                          |  |                         | 2,716  |   |                   |   |       |              |  |   | 5,951  |   |  |   | 8,667  |  
|                                                  |  |                         |        |  
|At and for the three months ended March 31, 2006: |  |                         |        |   |                   |   |        |              |  |   |        |   |  |   |        |  
|Revenues                                          |  |                         | 5,801  |   |                   |   | 1,817  |              |  |   |       |   |  |   | 7,618  |  
|Segment income (loss)                             |  |                         | 9      |   |                   |   | (2,883 | )            |  |   | (156   | ) |  |   | (3,030 | )
|Segment assets                                    |  |                         | 26,513 |   |                   |   | 3,851  |              |  |   | 5,951  |   |  |   | 36,315 |  
|Goodwill                                          |  |                         | 2,716  |   |                   |   |       |              |  |   | 5,951  |   |  |   | 8,667  |  

For segment reporting purposes, unallocated amounts consist of goodwill and acquired intangible
asset values and related amortization amounts with respect to the 2002 acquisition of Menerva Technologies, Inc. Interest revenue, interest expense, other significant non-cash items, income tax expense or benefit, and unusual items that are
attributable to the segments do not have a significant effect on the financial results of the segments. In performing the annual goodwill impairment test, all goodwill is assigned to the reportable segments.

NOTE 7. RESTRUCTURING AND OTHER CHARGES

In 2003 and 2004,
the Company took several actions to reduce its operating expenses in order to better align its cost structure with projected revenues and to streamline its operations in advance of a planned (and subsequently terminated) sale of its health and life
sciences operation. These actions included the closing of its office in Chicago, Illinois and the partial closing of its facility in London, England. With respect to the Chicago and London office closings, the Company had determined the fair value
of the remaining liabilities of the unused space (net of estimated sublease rentals) for each lease as of the respective cease-use dates.

In the quarters ended March 31, 2007 and 2006, the Company realized charges of $62,000 and $8,000, respectively, in connection with the amortization of its long-term lease restructuring accruals for its Chicago and London facilities.



14



---

##### Table of Contents

A rollforward of the Companys accrued liability for restructuring and other charges, consisting
entirely of lease costs, is as follows:



|                                                             |  |   |     |  
|------------------------------------------------------------ |  | - | --- | -
|(Amounts in thousands)                                       |  |   |    
|Balance at December 31, 2006                                 |  | $ | 985 |  
|Activity in three months ended March 31, 2007:               |  |   |     |  
|Restructuring charge                                         |  |   | 62  |  
|Payments net of sublease receipts                            |  |   | (69 | )
|                                                             |  |   |     |  
|Balance at March 31, 2007                                    |  | $ | 978 |  
|                                                             |  |   |     |  
|Current portion  included in accrued expenses               |  | $ | 226 |  
|                                                             |  |   |     |  
|Noncurrent portion  included in other long-term liabilities |  | $ | 752 |  
|                                                             |  |   |     |  

NOTE 8. VALUATION AND QUALIFYING ACCOUNTS

A rollforward of the Companys allowance for doubtful accounts at March 31 is as follows:



|                        |  |      |     |      |   |     |  
|----------------------- |  | ---- | --- | ---- | - | --- | -
|(Amounts in thousands)  |  | 2007 |     | 2006 |  
|Balance at January 1,   |  | $    | 137 |      | $ | 525 |  
|(Write offs)/recoveries |  |      | 1   |      |   | (85 | )
|                        |  |      |     |      |   |     |  
|Balance at March 31,    |  | $    | 138 |      | $ | 440 |  
|                        |  |      |     |      |   |     |  

NOTE 9. PRIVATE PLACEMENT

On November 6, 2006, the Company completed a private placement of its securities, issuing 3,535,566 shares of its common stock and common stock purchase warrants to purchase up to an additional 1,060,663 shares
of common stock. The per unit price of the private placement offering was $1.98, with each unit comprised of one share of common stock and a warrant to purchase three-tenths of a share of common stock. The warrants are exercisable at $2.11 per share
until November 2011. Net proceeds to the Company were approximately $6.5 million, after deducting commissions and other fees. These shares of common stock and those issuable upon exercise of the warrants have been registered with the Securities and
Exchange Commission and the registration became effective as of February 5, 2007.



|ITEM 2. | MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|------- | -------------------------------------------------------------------------------------

You should read the following discussion of our financial condition and results of operations in conjunction with our financial statements and related
notes. In addition to historical information, the following discussion and other parts of this report contain forward-looking statements that involve risks and uncertainties. Our actual results may differ materially from those anticipated by such
forward-looking statements due to various factors, including, but not limited to, those set forth under "Risk Factors" in Part II, Item 1A, and elsewhere, in this report.



15



---

##### Table of Contents

OVERVIEW

We
provide software and related services that allow our clients to more effectively manage their contract-based, business-to-business relationships through the entirety of the contract management lifecycle. We operate our business in two segments:
health and life sciences and industry solutions. The health and life sciences line of business markets and sells our products and services to companies in the life sciences industries, including pharmaceutical and medical product companies,
wholesale distributors and managed care organizations. The industry solutions line of business targets all other industries, with an emphasis on consumer products, foodservice, disposables, oil/gas/energy, consumer durables, industrial products,
chemicals, apparel, and telecommunications.

Our primary products and services were originally developed to manage complex contract
purchasing relationships in the healthcare industry. Our software is currently licensed by 17 of the 20 largest world-wide pharmaceutical manufacturers, ranked according to 2005 annual pharma revenues. As the depth and breadth of our product suites
have expanded, we have added companies in the industry solutions markets to our customer base.

We have generated revenues from both
products and services. Recurring revenue, which consists of maintenance, support and hosting fees directly related to our licensed software products and product subscription revenues, accounted for 53.0% of net revenues in the three months ended
March 31, 2007 versus 49.6% of net revenues in the three months ended March 31, 2006. Services revenue, which is comprised of professional service fees derived from consulting, installation, business analysis and training services related
to our software, accounted for 35.8% of net revenues in the three months ended March 31, 2007 versus 36.1% of net revenues in the three months ended March 31, 2006. License revenue, which consists of non-recurring license fees generated
from perpetual license agreements, accounted for 11.2% of net revenues in the three months ended March 31, 2007 versus 14.3% of net revenues in the three months ended March 31, 2006.

We implemented a number of employee headcount reductions and office downsizings during the period June 2001 through March 2004, after which our aggregate
quarterly spending on cost of products and services, sales and marketing, research and development and general and administrative expenses (excluding amortization and noncash stock compensation) remained fairly steady  ranging from $9.2
million to $10.4 millionthrough the first quarter of 2006. In early 2006, we began increasing our spending, primarily on research and development and professional services, in order to (i) accelerate development of future releases of our
product offerings in the health and life sciences segment, (ii) work on resolving defects in one of our software products, as explained in further detail in Critical Accounting Policies  Revenue Recognition in this
Item 2, and (iii) augment staff levels at a number of professional services engagements, primarily in connection with implementations of the software product with performance defects at customer sites. During the three-month period ended
March 31, 2007, our spending on research and development as a percentage of revenues reached its highest level in seven years and we expect that this spending will continue at high levels relative to our revenues for much of 2007. Our total
employee headcount has increased from 170 at March 31, 2004 to 184 at March 31, 2007.

In August 2005, the Company announced the
departure of its Chief Executive Officer, A. Leigh Powell, and its Chief Operating Officer, Terrence M. Nicholson. In connection with the resignation of these executives, we incurred $350,000 in future severance and benefit costs in 2005. Also,
Yorgen Edholm was appointed Acting President and Chief Executive Officer, and John A. Rade was appointed Chairman of the Board of Directors with certain executive powers. In February 2006, Mr. Edholm resigned as Acting President and Chief
Executive Officer while remaining on the Board of Directors, and Mr. Rade assumed the position of Acting President and Chief Executive Officer on an interim basis. In August 2006, Mr. Rade was appointed President and Chief Executive
Officer on a permanent basis.



16



---

##### Table of Contents

On November 6, 2006, we completed a private placement of our securities, issuing 3,535,566 shares of
our common stock and common stock purchase warrants to purchase up to an additional 1,060,663 shares of common stock. The per unit price of the private placement offering was $1.98, with each unit comprised of one share of common stock and a warrant
to purchase three-tenths of a share of common stock. The warrants are exercisable at $2.11 per share until November 2011. Net proceeds to the Company were approximately $6.5 million, after deducting commissions and other fees.

CRITICAL ACCOUNTING POLICIES

Revenue Recognition

We generate revenues from licensing our software and providing professional services, training and maintenance and support services. Software license
revenues are attributable to the addition of new customers and the expansion or renewal of existing customer relationships through licenses covering additional users, licenses of additional software products and license renewals.

We recognize software license fees upon execution of a signed license agreement and delivery of the software to customers, provided there are no
significant post-delivery obligations, the payment is fixed or determinable and collection is probable. In multiple-element arrangements, we allocate a portion of the total fee to professional services, training and maintenance and support services
based on the fair value of those elements, which is defined as the price charged when those elements are sold separately. The residual amount is then allocated to the software license fee. In cases where we agree to deliver unspecified additional
products in the future, the license fee is recognized ratably over the term of the arrangement beginning with the delivery of the first product. In cases where we agree to deliver specified additional products or upgrades in the future, recognition
of the entire license fee, including any related maintenance and support fees, is deferred until after the specified additional products or upgrades are delivered and made generally available to all customers. If an acceptance period is required,
revenues are deferred until customer acceptance. In cases where collection is not deemed probable, we recognize the license fee as payments are received. In cases where significant production or customization is required prior to attaining
technological feasibility of the software, license fees are recognized on a percentage-of-completion basis and are credited to research and development expenses as a funded development arrangement. After the software attains technological
feasibility, recognizable license fees are reported as product revenue.

In 2007, we began to classify our reported net revenues into three
revenue categories  Recurring, Services and License revenues  after having previously reported our revenues as being either Product or Service. Recurring revenue consists of (i) fees generated from the provision of maintenance,
support, and hosting services and (ii) subscription revenues. Services revenue is now comprised of professional service and training fees and reimbursable out-of-pocket expenses. License revenue consists of non-recurring license fees generated
from perpetual license agreements.

We offer current and prospective customers the option to enter into a subscription agreement as an
alternative to our standard perpetual license contract model. Management believes its subscription offering has expanded the market to customers that find regular subscription payments an easier and more flexible implementation of our software, and
subscription arrangements have the potential to provide us with smoother and more predictable revenue growth. The standard subscription arrangement is presently a fixed fee agreement over



17



---

##### Table of Contents

three to five years, covering license fees, unspecified new product releases and maintenance and support, generally payable in equal quarterly installments
commencing upon execution of the agreement. In approximately half of the agreements that have been executed to date, the subscription arrangement converts free-of-charge to a perpetual license after the completion of the initial term plus any
extensions, generally after five years, after which time the customer would have the option of paying for the continuation of maintenance and support. We recognize all revenue from subscription based arrangements ratably over the term of the
subscription agreement commencing upon delivery of the initial product. Subscription installment amounts that are not yet contractually billable to customers are not reflected in deferred revenues on our consolidated balance sheet.

Maintenance and customer support fees are recognized ratably over the term of the maintenance contract, which is generally twelve months. When
maintenance and support is included in the total license fee, we allocate a portion of the total fee to maintenance and support based upon the price paid by the customer when sold separately, generally as renewals in the second year.

Professional service revenues are recognized as the services are performed. If conditions for acceptance exist, professional service revenues are
recognized upon customer acceptance. For fixed fee professional service contracts, we provide for anticipated losses in the period in which the loss is probable and can be reasonably estimated. Training revenues are recognized as the services are
provided. Included in training revenues are registration fees received from participants in our off-site user training conferences.

Payments received from customers at the inception of a maintenance period are treated as deferred service revenues and recognized ratably over the maintenance period. Payments received from customers in advance of product shipment or
revenue recognition are treated as deferred product revenues and recognized when the product is shipped to the customer or when otherwise earned.

Subscription arrangements, including perpetual license arrangements with rights to unspecified additional products that are treated as subscriptions for accounting purposes, now represent a significant proportion of our new licenses. In
2006, 17 of the 29 license deals (minimum value of $50,000) that were sold are being treated as subscription arrangements for accounting purposes. And in the three months ended March 31, 2007, four of the seven license deals (minimum value of
$50,000) that were sold are likewise being accounted for as subscriptions. During the three months ended March, 31, 2007 and 2006, we recognized $944,000 and $555,000, respectively, in recurring revenue related to such agreements. For 2007, we
anticipate that subscription arrangements will continue to represent a significant proportion of new license sales.

During the third
quarter of 2005, we became aware of certain defects in the then-current version of one of our software products, which was first shipped to customers in the fourth quarter of 2004. These defects, which were not identified in pre-release product
testing, affected the performance of the software for a portion of our customers depending on each customers particular implementation environment and its intended use of the software. Because certain concessions have been made to customers in
connection with these defects, we have generally not recognized revenue from sales of this software product and related implementation services beginning in the third quarter of 2005, except in those cases in which it was determined that the
customer was not likely to be affected by the known, unresolved software defects. During 2006, new versions of the software were released, but we continued to experience problems with implementations at several customer sites. In the first quarter
of 2007, we released a new version of the software which was designed to resolve known performance defects with minimal additional functionality. However, we intend to continue deferring revenue in connection with license sales, maintenance and
support, and implementation services for this software product until it has been demonstrated at multiple



18



---

##### Table of Contents

customer sites that the new release of the software is free of significant performance defects. As of March 31, 2007 and December 31, 2006, we have
reversed and deferred cumulative amounts of $4.0 million and $3.5 million, respectively, of otherwise-recognizable product and service revenue, based in part on our estimate of the fair value of concessions to be made until the remaining defect is
resolved, and partly on our determination that license fees were not fixed and determinable because of the possibility of future concessions. Also, see Risk Factor entitled We Cannot Guarantee That Our Deferred Revenue Will Be Recognized as
Planned in Part II, Item 1A of this filing.

Stock-based Compensation:

On January 1, 2006, we adopted Statement of Financial Accounting Standards (FAS) No. 123 (revised 2004) (FAS 123(R)),
Share-based Payment. Under FAS 123(R), we measure and record the compensation cost of employee and director services received in exchange for stock option grants and other equity awards based on the grant-date fair value of the awards.
The values of the portions of the awards that are ultimately expected to vest are recognized as expense over the requisite service periods. We account for stock options and awards granted to non-employees other than directors using the fair-value
method.

Under the fair-value method, compensation associated with equity awards is determined based on the estimated fair value of the
award itself, measured using either current market data or an established option pricing model. The measurement date for employee and director awards is generally the date of grant. The measurement date for awards granted to non-employees other than
directors is generally the date that performance of certain services is complete.

Our estimates of the fair value of stock option grants
were made using the Black-Scholes option pricing model with the following assumptions and resulted in the following weighted average grant-date fair values of options granted during the three months ended March 31:



|                                                                            |  |           |  |          
|--------------------------------------------------------------------------- |  | --------- |  | ---------
|                                                                            |  | 2007      |  | 2006     
|Risk-free interest rates                                                    |  | 4.50%     |  | 4.86%    
|Dividend yield                                                              |  |          |  |         
|Expected volatility                                                         |  | 60%       |  | 70%      
|Expected term (in years)                                                    |  | 6.11-7.50 |  | 5.75-6.25
|Weighted average grant-date fair value of options granted during the period |  | $1.12     |  | $1.04    

We use historical volatility of the Companys common stock to estimate expected volatility. Beginning in
2005, the expected term of options granted is estimated to be equal to the average of the contractual life of the options and the grants average vesting period. The risk-free interest rate is derived quarterly from the published US Treasury
yield curve, based on expected term, in effect as of the last several days of the quarter.

Allowance for Doubtful Accounts

We record provisions for doubtful accounts based on a detailed assessment of our accounts receivable and related credit risks. In estimating the allowance
for doubtful accounts, management considers the age of the accounts receivables, our historical write-off experience, the credit worthiness of customers and the economic conditions of the customers' industries and general economic conditions, among
other factors. Should any of these factors change, the estimates made by management will also change, which could affect the level of our future provision for doubtful accounts. If the assumptions we used to calculate these estimates do not properly
reflect future collections, there could be an impact on future reported results of operations. The provisions for doubtful accounts are included in general and administrative expenses in the consolidated statements of operations.



19



---

##### Table of Contents

Acquired Intangible Assets

Acquired intangible assets (excluding goodwill) are amortized on a straight-line basis over their estimated useful lives and reviewed for impairment on an annual basis, or on an interim basis if an event or
circumstance occurs between annual tests indicating that the assets might be impaired. The impairment test will consist of comparing the cash flows expected to be generated by the acquired intangible asset to its carrying amount. If the asset is
considered to be impaired, an impairment loss will be recognized in an amount by which the carrying amount of the asset exceeds its fair value.

Goodwill

Goodwill is tested for impairment at the reportable segment level using a two-step approach. The first step is to
compare the fair value of a reporting unit to its carrying amount, including goodwill. If the fair value of the reporting unit is greater than its carrying amount, goodwill is not considered impaired and the second step is not required. If the fair
value of the reporting unit is less than its carrying amount, the second step of the impairment test measures the amount of the impairment loss, if any, by comparing the implied fair value of goodwill to its carrying amount. If the carrying amount
of goodwill exceeds its implied fair value, an impairment loss is recognized equal to that excess. The implied fair value of goodwill is calculated in the same manner that goodwill is calculated in a business combination, whereby the fair value of
the reporting unit is allocated to all of the assets and liabilities of that unit (including any unrecognized intangible assets), with the excess purchase price over the amounts assigned to assets and liabilities representing the implied
fair value of goodwill. Goodwill is tested for impairment at least annually, or on an interim basis if an event occurs or circumstances change that would likely reduce the fair value of a reporting unit below its carrying value. If the assumptions
we used to estimate fair value of goodwill change, there could be an impact on future reported results of operations.

Deferred Tax Assets

A deferred tax asset or liability is recorded for temporary differences in the bases of assets and liabilities for book and tax
purposes and loss carry forwards based on enacted tax rates expected to be in effect when these temporary items are expected to reverse. Valuation allowances are provided to the extent it is more likely than not that all or a portion of the deferred
tax assets will not be realized.

Product Indemnification

Our agreements with customers generally include certain provisions obligating us to indemnify the customer against losses, expenses, and liabilities from damages that may be awarded against the customer in the event
that our products are found to infringe upon a patent, copyright, trademark, or other proprietary right of a third party. The agreements generally seek to limit the scope of remedies for such indemnification obligations in a variety of
industry-standard respects, including our right to replace an infringing product. To date, we have not had to reimburse any of our customers for any losses related to these indemnification provisions and no claims were outstanding as of
March 31, 2007. We do not expect that any significant impact on financial position or the results of operations will result from these indemnification provisions.



20



---

##### Table of Contents

Research and Development Costs

Research and development costs are charged to operations as incurred. Based on our product development process, technological feasibility is established upon completion of a working model. Costs incurred by the
Company between completion of the working model and the point at which the product is ready for general release have not been material. As such, all software development costs incurred to date have been expensed as incurred.

RESULTS OF OPERATIONS

COMPARISON OF THE THREE MONTH PERIODS ENDED MARCH 31,
2007 AND 2006

NET REVENUES

Net revenues
increased by $734,000, or 9.6%, to $8.4 million for the quarter ended March 31, 2007 from $7.6 million for the quarter ended March 31, 2006. Recurring revenue increased by $645,000, or 17.1%, to $4.4 million for the quarter ended
March 31, 2007 from $3.8 million in the same period a year earlier, primarily attributable to a $394,000, or 71.6%, increase in subscription revenue. As indicated above in this Item 2, subscription arrangements have represented a
significant proportion of recent license deals, as evidenced by an increase of $5.9 million, or 60.0%, as of March 31, 2007 in the total value of unamortized software subscriptions (i.e., the remaining value of non-cancellable subscription
contracts that have not yet been recognized into revenue) relative to the year earlier period. Service revenue increased by $239,000, or 8.7%, to $3.0 million, as demand for implementation services increased in our health and life sciences segment.
License revenue decreased by $150,000, or 13.8%, to $940,000 for the quarter ended March 31, 2007 from $1.1 million for the quarter ended March 31, 2006, a trend which is consistent with the growth of our subscription business.

As indicated in the table below, the gross value of license contracts sold during the first quarter of 2007 decreased by $401,000, or 10.0%, versus
the first quarter of 2006, due to a decrease in the number of license transactions (minimum value of $50,000) from 8 to 7, partially offset by an increase in the average selling price. Consistent with recent reporting periods, most of the revenue
from the license transactions executed in the first three months of 2007 was deferred to future reporting periods. We believe that a significant proportion of future license contracts will likewise be subscription arrangements or will be perpetual
licenses that have conditions, such as software acceptance testing, resulting in deferral of license revenue recognition to later reporting periods. As a result, in future reporting periods we expect reportable license revenues to exclude much of
the gross value generated from contracts entered into in those periods.

Reconciliation of Gross Value of License Transactions to
Reportable License Revenue



|                                                                                       |  |                          |       |          |   |         |  |         |       |         |   |       |  |   |      
|-------------------------------------------------------------------------------------- |  | ------------------------ | ----- | -------- | - | ------- |  | ------- | ----- | ------- | - | ----- |  | - | -----
|                                                                                       |  | Three Month Period ended
|                                                                                       |  | 3/31/07                  |       | 12/31/06 |   | 9/30/06 |  | 6/30/06 |       | 3/31/06
|                                                                                       |  | (AMOUNTS IN THOUSANDS)  
|Gross value of license contracts sold:                                                 |  |                          |       |          |   |         |  |         |       |         |   |       |  |   |      
|Health and Life Sciences                                                               |  | $                        | 3,296 |          | $ | 3,789   |  | $       | 1,417 |         | $ | 3,772 |  | $ | 3,457
|Industry Solutions                                                                     |  |                          | 306   |          |   | 232     |  |         | 342   |         |   | 848   |  |   | 546  
|                                                                                       |  |                          |       |          |   |         |  |         |       |         |   |       |  |   |      
|                                                                                       |  |                          | 3,602 |          |   | 4,021   |  |         | 1,759 |         |   | 4,620 |  |   | 4,003
|                                                                                       |  |                          |       |          |  
|Less value of license contracts sold in current period and deferred to future periods: |  |                          |       |          |   |         |  |         |       |         |   |       |  |   |      
|Health and Life Sciences                                                               |  |                          | 2,436 |          |   | 3,754   |  |         | 980   |         |   | 3,772 |  |   | 2,382
|Industry Solutions                                                                     |  |                          | 226   |          |   | 219     |  |         | 334   |         |   | 831   |  |   | 531  
|                                                                                       |  |                          |       |          |   |         |  |         |       |         |   |       |  |   |      
|                                                                                       |  |                          | 2,662 |          |   | 3,973   |  |         | 1,314 |         |   | 4,603 |  |   | 2,913
|                                                                                       |  |                          |       |          |   |         |  |         |       |         |   |       |  |   |      
|License revenue recorded:                                                              |  |                          |       |          |   |         |  |         |       |         |   |       |  |   |      
|Health and Life Sciences                                                               |  |                          | 860   |          |   | 35      |  |         | 437   |         |   |      |  |   | 1,075
|Industry Solutions                                                                     |  |                          | 80    |          |   | 13      |  |         | 8     |         |   | 17    |  |   | 15   
|                                                                                       |  |                          |       |          |   |         |  |         |       |         |   |       |  |   |      
|                                                                                       |  | $                        | 940   |          | $ | 48      |  | $       | 445   |         | $ | 17    |  | $ | 1,090
|                                                                                       |  |                          |       |          |   |         |  |         |       |         |   |       |  |   |      



21



---

##### Table of Contents

The above financial information is provided as additional information and is not in accordance with or an
alternative to generally accepted accounting principles, or GAAP. We believe its inclusion can enhance an overall understanding of our past operational performance and also our prospects for the future. This reconciliation of license revenues is
made with the intent of providing a more complete understanding of our sales performance, as opposed to GAAP revenue results, which do not include the impact of newly-executed subscription agreements and other deferred license arrangements that are
material to the ongoing performance of our business. This information quantifies the various components comprising current revenue, which in each period consists of the total value of licenses sold in current periods, plus license revenue recorded
in the current period from contracts sold in prior periods, less the value of license contracts sold in the current period that is not yet recognizable. Included in the gross value of license contracts sold amounts are license and non-cancelable
subscription fee obligations that are not currently recognizable as product revenue upon execution of the license agreement because all the requirements for revenue recognition (see Critical Accounting Policies  Revenue Recognition
in this Item 2) are not present, such as the presence of extended payment terms, future software deliverables, or customer acceptance provisions. The gross value of license contracts sold also includes amounts that are not yet contractually
billable to customers and any such unbilled amounts are not reflected in deferred revenues on our consolidated balance sheet. Management uses this information as a basis for planning and forecasting core business activity in future periods and
believes it is useful in understanding our results of operations. Also, payouts under our sales compensation and executive bonus plans are based in large part on the gross values of license contracts sold each period. The presentation of this
additional revenue information is not meant to be considered in isolation or as a substitute for revenues reported in accordance with GAAP in the United States. There can be no assurance that the full value of licenses sold and deferred to future
reporting periods will ultimately be recognized as revenues.

Revenues derived from our health and life sciences segment increased by
$582,000, or 10.0%, to $6.4 million for the quarter ended March 31, 2007 from $5.8 million in the year earlier period. This increase was primarily attributable to increases of (i) $309,000, or 58.3%, in subscription revenue,
(ii) $255,000, or 12.6%, in non-subscription maintenance and support revenue, and (iii) $253,000, or 12.2%, in professional services revenue, partially offset by a decrease of $215,000, or 20.0%, in license revenue. As indicated in the
above table, the gross values of license contracts sold in this segment during the quarter ended March 31, 2007 decreased by $161,000, or 4.7%, versus the same quarter in 2006 due to a decrease in the number of license transactions partially
offset by an increase in the average selling price.

Revenues derived from our industry solutions segment increased by $153,000, or 8.4%,
to $2.0 million for the quarter ended March 31, 2007 versus $1.8 million in the same quarter in 2006. This increase was comprised principally of a $100,000, or 66.0%, increase in hosting fee revenue and an $85,000, or 376.2%, increase in
subscription revenue. As indicated in the above table, the gross values of license contracts sold in this segment during the quarter ended March 31, 2007 decreased by $240,000, or 44.0%, versus the first quarter in 2006. Licensing activity in
the industry solutions segment was negatively affected by product defect issues in one of our key software products (see Critical Accounting Policies  Revenue Recognition in this Item 2 above) and this negative impact should
continue until the software defects are resolved, which Management anticipates will occur during mid-2007.

OPERATING EXPENSES

COST OF RECURRING REVENUE. Cost of recurring revenue consists primarily of payroll and related costs for providing maintenance and support services, and,
to a lesser extent, hosting services. Cost of recurring revenue increased by $204,000, or 14.1%, to $1.7 million for the quarter ended March 31, 2007 from $1.4 million in the year earlier period. This increase is



22



---

##### Table of Contents

primarily attributable to (i) an increase of $102,000 in hosting costs incurred by our subsidiary based in the United Kingdom, in connection with the
transfer of hosting business from the parent company, and (ii) an increase of $96,000 in salary and related costs in connection with increased staff levels and merit salary increases. As a percentage of recurring revenue, cost of recurring
revenue decreased to 37.3% for the quarter ended March 31, 2007 from 38.3% for the quarter ended March 31, 2006.

COST OF
SERVICES REVENUE. Cost of services revenue consists primarily of payroll and related costs and subcontractor fees for providing implementation, consulting and training services. Cost of services revenue increased by $586,000, or 24.7%, to $3.0
million for the quarter ended March 31, 2007 from $2.4 million in the year earlier period. This increase is primarily attributable to increases of (i) $429,000 in the cost of consultants, resulting from the need to augment our professional
services staff on certain implementation engagements, and (ii) $103,000 in salary and related costs that resulted from increased staff levels and merit salary increases. As noted in Critical Accounting Policies  Revenue
Recognition in this Item 2, one of our software products has been experiencing performance defects, and consequently we have increased outsourced staffing on certain implementation engagements without a corresponding increase in revenue.
As a percentage of services revenue, cost of services revenue increased to 99.0% for the quarter ended March 31, 2007 from 86.2% for the quarter ended March 31, 2006.

COST OF THIRD PARTY TECHNOLOGY. Cost of third party technology, which consists of amounts due to third parties for royalties related to integrated
technology, has not been significant historically. Cost of third party technology decreased by $1,000 to $76,000 for the three months ended March 31, 2007 as compared to the year earlier period.

AMORTIZATION OF ACQUIRED INTANGIBLE ASSETS. Amortization of acquired intangible assets related to our acquisitions amounted to $46,000 in the quarter
ended March 31, 2007, which represents a decrease of $297,000, or 86.6%, from $343,000 recorded in the quarter ended March 31, 2006. This decrease is attributable to the intangible assets in connection with the acquisitions of NetReturn,
LLC and Menerva Technologies, Inc. becoming fully-amortized during the first quarter of 2006.

SALES AND MARKETING. Sales and marketing
expenses consist primarily of payroll and related benefits for sales and marketing personnel, commissions for sales personnel, travel costs, recruiting fees, expenses for trade shows and advertising and public relations expenses. Sales and marketing
expenses increased by $241,000, 11.6%, to $2.3 million in the three months ended March 31, 2007 as compared to $2.1 million in the three months ended March 31, 2006. This increase was primarily attributable to a $227,000 increase in
commission costs that resulted from (i) higher draw payments relative to the prior year and (ii) an increase in the value of license bookings that was subject to incentive compensation. As a percentage of total net revenues, sales and
marketing expense increased slightly to 27.7% for the quarter ended March 31, 2007 from 27.2% for the quarter ended March 31, 2006.

RESEARCH AND DEVELOPMENT. Research and development expenses consist primarily of payroll and related costs for development personnel and external consulting costs associated with the development of our products and services. Research and
development costs, including the costs of developing computer software, are charged to operations as they are incurred. Research and development expenses increased significantly by $1.3 million, or 44.5%, to $4.3 million for the quarter ended
March 31, 2007 versus $3.0 million for the quarter ended March 31, 2006. This increase was principally comprised of increases of (i) $571,000 in salary and related costs, resulting from an increase in average headcount of 10
employees, and (ii) $391,000 in consulting costs, and a $171,000 decrease in funded development credits. The increase in salary-related and consulting costs is primarily attributable to our ramping up resources for the development of next
generation products for our health and life sciences



23



---

##### Table of Contents

segment and also to our efforts to resolve product defect issues in one of our key software products (see Critical Accounting Policies  Revenue
Recognition in this Item 2 above). Consequently, research and development expense increased significantly as a percentage of total net revenues to 51.5% for the quarter ended March 31, 2007 from 39.1% for the quarter ended
March 31, 2006.

GENERAL AND ADMINISTRATIVE. General and administrative expenses consist primarily of salaries and related costs for
personnel in our administrative, finance and human resources departments, and legal, accounting and other professional service fees. General and administrative expenses increased by $139,000, or 10.6%, to $1.5 million for the quarter ended
March 31, 2007 from $1.3 million for the quarter ended March 31, 2006. This increase in general and administrative expenses was primarily attributable to a $124,000 increase in noncash stock compensation costs, resulting mostly from recent
stock option grants to our chief executive officer, and a $94,000 increase in salary and related costs, which was caused by small growth in quarterly average headcount and merit pay increases, partially offset by a $53,000 reduction in audit fees.
As a percentage of total net revenues, general and administrative expenses increased slightly to 17.4% for the quarter ended March 31, 2007 from 17.2% for the quarter ended March 31, 2006.

DEPRECIATION. Depreciation expense increased by $17,000, or 10%, from $171,000 in the first quarter of 2006 to $188,000 in the first quarter of 2007.
This increase is principally attributable to higher levels of spending for furniture, equipment and software additions in the year 2006 ($974,000) relative to the year 2003 ($650,000), the majority of these asset additions being depreciated over a
three-year life.

RESTRUCTURING AND OTHER CHARGES. In the quarter ended March 31, 2007, we recorded $62,000 in charges related to
efforts in prior quarters to streamline operations, which includes the amortization of the discount incorporated in the initial restructuring provisions for future lease costs in connection with the Chicago and London office downsizings, This
charge, which is substantially higher than 2006s average quarterly rate of $26,000, incorporates a recent increase in future lease rate projections for the Chicago office space, most of which is not recoverable from sub lessees.

OTHER INCOME, NET

Other income, net, increased by $43,000,
or 33%, in the quarter ended March 31, 2007 as compared to the quarter ended March 31, 2006. This increase was principally comprised of a $29,000 increase in interest income, as significantly higher yields more than offset a decrease in
average invested balances relative to the year ago period.

PROVISION FOR INCOME TAXES

We incurred operating losses for all quarters in 2006 and the first quarter of 2007 and have consequently recorded a valuation allowance for the full
amount of our net deferred tax asset, which consists principally of our net operating loss carryforwards, as the future realization of the tax benefit is uncertain. No provision or benefit for income taxes has been recorded in the three-month
periods ended March 31, 2007 and 2006.

LIQUIDITY AND CAPITAL RESOURCES

On November 6, 2006, we completed a private placement of our common stock and warrants, which resulted in our receipt of approximately $6.5 million in net proceeds. (See Note 9 to the condensed consolidated
financial statements.)



24



---

##### Table of Contents

In the first quarter of 2007 and the year ended December 31, 2006, we entered into several capital
lease financing arrangements with different financial institutions in order to finance the purchase of computer equipment and related services amounting to $114,000 and $425,000, respectively.

At March 31, 2007, we had cash and cash equivalents of $15.2 million, as compared to cash and cash equivalents of $17.2 million at March 31,
2006. Also at March 31, 2007, we had no long-term or short-term debt, other than obligations under capital lease financings. The current and non-current restricted cash balances of $80,000 and $428,000, respectively, at March 31, 2007
represent cash amounts held on deposit as security on two long-term real property lease obligations.

Net cash used in operating activities
for the three months ended March 31, 2007 was $1.9 million, as compared to net cash provided by operating activities of $229,000 in the three months ended March 31, 2006. For the three months ended March 31, 2007, net cash used in
operating activities consisted principally of the net loss of $4.5 million, less non-cash items depreciation and amortization of $234,000 and stock-based compensation of $553,000, partially offset by a $1.2 million decrease in accounts
receivable and a $493,000 increase in deferred revenue. The $1.2 million reduction in accounts receivable was primarily attributable to a decrease in deferred maintenance and support renewals relative to the prior quarter; because a significant
portion of our customers request a calendar year billing cycle for maintenance and support renewals regardless of the anniversary date of their license agreement, maintenance and support renewal invoicing volume is generally higher in the fourth
quarter each year. The $493,000 increase in deferred revenue was primarily attributable to (i) current period deferrals of license fees and professional service revenues of $391,000 and $193,000, respectively, in connection with software
performance-related deferrals noted in Critical Accounting Policies  Revenue Recognition in this Item 2, and (ii) a $176,000 net increase in deferred subscription fees in connection with newly-executed subscription
agreements, partially offset by a $241,000 decrease in deferred maintenance and support fees resulting from the seasonality in the invoicing of maintenance and support renewals discussed above.

For the three months ended March 31, 2006, net cash provided by operating activities consisted principally of a $2.4 million decrease in accounts
receivable and a $797,000 increase in deferred revenue, mostly offset by our net loss of $3.0 million  as reduced by non-cash items depreciation and amortization of $514,000 and stock-based compensation of $257,000  and a $601,000
decrease in accrued expenses. The $2.4 million decrease in accounts receivable was principally attributable to (i) improved collections experience, (ii) a $1.3 million decrease in maintenance and support renewal billings relative to the
prior quarter  due principally to the seasonality in renewal billings discussed above, and (iii) a $1.2 million decrease in perpetual license billings during the quarter ended March 31, 2006 versus the immediately preceding quarter.
The $797,000 increase in deferred revenue is mostly attributable to the deferral of $552,000 in perpetual license fees from deals closed in the first quarter of 2006 because of contractual acceptance provisions, and also to the continued increase in
unearned subscription billings. The $601,000 decrease in accrued expenses is primarily due to reductions in the accruals for unpaid salaries, bonuses and severance as of March 31, 2006 versus December 31, 2005.

Net cash used in investing activities, consisting solely of property and equipment additions, was $127,000 for the three months ended March 31, 2007
and $210,000 for the three months ended March 31, 2006. In the first quarter of 2007, $114,000 of property and equipment additions was acquired under capital leases, as compared to no such additions in the first quarter of 2006.



25



---

##### Table of Contents

Net cash provided by financing activities was $3,000 in the three months ended March 31, 2007,
consisting of $53,000 in proceeds from stock option exercises largely offset by $50,000 in payments on capital lease obligations. Net cash provided by financing activities was $360,000 in the three months ended March 31, 2006, consisting
principally of $300,000 and $61,000, respectively, in proceeds from warrant and stock option exercises.

We currently anticipate that our
cash and cash equivalents of $15.2 million will be sufficient to meet our anticipated needs for working capital, capital expenditures, and acquisitions for at least the next 12 months. Our future long-term capital needs will depend significantly on
the rate of growth of our business, our rate of loss, the mix of subscription licensing arrangements versus perpetual licenses sold, possible acquisitions, the timing of expanded product offerings and the success of these offerings if and when they
are launched. Accordingly, any projections of future long-term cash needs and cash flows are subject to substantial uncertainty. If our current balance of cash and cash equivalents is insufficient to satisfy our long-term liquidity needs, we may
seek to sell additional equity or debt securities to raise funds, and those securities may have rights, preferences or privileges senior to those of the rights of our common stock. In connection with a sale of stock, our stockholders would
experience dilution. In addition, we cannot be certain that additional financing will be available to us on favorable terms when required, or at all. Also, our stock price may make it difficult for us to raise additional equity financing.

CONTRACTUAL OBLIGATIONS



|                              |  |                                           |       |                  |   |           |  |           |       |                   |   |       |  |   |  
|----------------------------- |  | ----------------------------------------- | ----- | ---------------- | - | --------- |  | --------- | ----- | ----------------- | - | ----- |  | - | -
|                              |  | Payments due by Period - Amounts in $000s
|                              |  | Total                                     |       | Less than 1 year |   | 1-3 years |  | 3-5 years |       | More than 5 years
|Capital Lease Obligations     |  | $                                         | 522   |                  | $ | 231       |  | $         | 291   |                   | $ |      |  | $ | 
|Operating Leases              |  |                                           | 5,814 |                  |   | 1,794     |  |           | 2,722 |                   |   | 1,298 |  |   | 
|                              |  |                                           |       |                  |   |           |  |           |       |                   |   |       |  |   |  
|Total Contractual Obligations |  | $                                         | 6,336 |                  | $ | 2,025     |  | $         | 3,013 |                   | $ | 1,298 |  | $ | 
|                              |  |                                           |       |                  |   |           |  |           |       |                   |   |       |  |   |  

Note: Capital Lease Obligations amounts in the above table include interest.



|ITEM 3. | QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
|------- | ----------------------------------------------------------

INTEREST RATE RISK

Our exposure to market risk for changes in interest rates relates primarily to our investment portfolio. We do
not use derivative financial instruments in our investment portfolio. The primary objective of our investment activities is to preserve principal while maximizing yields without assuming significant risk. This is accomplished by investing in
diversified investments, consisting primarily of short-term investment-grade securities. Due to the nature of our investments, we believe there is no material risk exposure. A 10% change in interest rates, either positive or negative, would not have
had a significant effect on either (i) our cash flows and reported net losses in the quarters ended March 31, 2007 and 2006, or (ii) the fair value of our investment portfolios at March 31, 2007 and December 31, 2006.

At March 31, 2007, our cash and cash equivalents consisted entirely of money market investments with remaining maturities of 90 days
or less when purchased and non-interest bearing checking accounts. Investments in marketable debt securities with maturities greater than 90 days and less than one year are classified as held-to-maturity short-term investments and are recorded at
amortized cost. Under current investment guidelines, maturities on short-term investments are restricted to one year or less. Investments in auction rate securities, with maturities which can be greater than one year but for which interest rates
reset in less than 90 days, are classified as available for sale securities and stated at fair market value.



26



---

##### Table of Contents

FOREIGN CURRENCY EXCHANGE RISK

We operate in certain foreign locations, where the currency used is not the U.S. dollar. However, these locations have not been, and are not currently expected to be, significant to our consolidated financial
statements. Changes in exchange rates have not had a material effect on our business.



|ITEM 4. | CONTROLS AND PROCEDURES
|------- | -----------------------

(a) Evaluation of
Disclosure Controls and Procedures.As required by Exchange Act Rule 13a-15(b), our management, with the participation of our Chief Executive Officer, or CEO, and Chief Financial Officer, or CFO, evaluated the effectiveness of our disclosure
controls and procedures as of March 31, 2007. The term disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, means controls and other procedures of a company that are designed to
ensure that information required to be disclosed by the company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SECs rules and
forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is
accumulated and communicated to the companys management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure (the Disclosure Controls and Procedures
Purposes). Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives, and management necessarily applies its judgment in
evaluating the cost-benefit relationship of possible controls and procedures. Based on this evaluation, our CEO and CFO concluded that, as of March 31, 2007, our disclosure controls and procedures were effective, to the reasonable
assurance level, for the Disclosure Controls and Procedures Purposes.

(b) Changes in Internal Control. No change in our
internal control over financial reporting occurred during the quarter ended March 31, 2007 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II. OTHER INFORMATION



|ITEM 1A. | RISK FACTORS
|-------- | ------------

In addition to other information in
this Form 10-Q, the following factors could cause actual results to differ materially from those indicated by forward-looking statements made in this Form 10-Q and presented elsewhere by management from time to time.

WE HAVE INCURRED SUBSTANTIAL LOSSES IN RECENT YEARS AND OUR RETURN TO PROFITABILITY IS UNCERTAIN

We incurred net losses of $9.3 million in the year ended December 31, 2005, $15.8 million in the year ended December 31, 2006, and $4.5 million
in the three months ended March 31, 2007, and we had an accumulated deficit at March 31, 2007 of $154.8 million. Our recent results have been impacted by a number of factors, including decisions to defer revenue associated with one of our
software products and relatively high research and development



27



---

##### Table of Contents

expense related to our efforts to resolve deficiencies in that product, and we cannot assure you that we will not be affected by these or other factors in
future periods. We cannot assure you that we will achieve sufficient revenues to become profitable in the future.

IT IS DIFFICULT FOR US TO PREDICT WHEN
OR IF SALES WILL OCCUR AND WHEN WE WILL RECOGNIZE THE REVENUE FROM OUR FUTURE SALES

Our clients view the purchase of our software
applications and related professional services as a significant and strategic decision. As a result, clients carefully evaluate our software products and services, often over long periods. The license of our software products may be subject to
delays if the client has lengthy internal budgeting, approval and evaluation processes, which are quite common in the context of introducing large enterprise-wide technology solutions. The length of this evaluation process varies from client to
client. Our clients have also shown a growing interest in licensing our software on a subscription basis, which results in deferral of payments and revenues that would otherwise be reportable if a traditional perpetual license were
executed. Our revenue forecasts and internal budgets are based, in part, on our best assumptions about the mix of future subscription licenses versus perpetual licenses. If we enter into a larger proportion of subscription
agreements than planned, we may experience an unplanned shortfall in revenues or cash during that quarter. A significant percentage of our expenses, particularly personnel costs and rent, are fixed costs and are based in part on
expectations of future revenues. We may be unable to reduce spending in a timely manner to compensate for any significant fluctuations in revenues and cash. Accordingly, shortfalls in current revenues, as we experienced in recent quarters, may cause
our operating results to be below the expectations of public market analysts or investors, which could cause the value of our common stock to decline.

WE
CANNOT GUARANTEE THAT OUR DEFERRED REVENUE WILL BE RECOGNIZED AS PLANNED

In 2005 we became aware of certain deficiencies in the
then-current version of one of our software products, which had first been shipped to customers in the fourth quarter of 2004. These deficiencies, which were not identified in pre-release product testing, affected the performance of the software for
a portion of our customers, depending on each customers particular implementation environment and its intended use of the software. We have generally not recognized revenue from sales of this software product and related implementation
services beginning in the third quarter of 2005, except in limited cases. As of March 31, 2007, we have deferred $4.0 million of otherwise-recognizable license and professional service revenue. We intend to continue deferring revenue in
connection with license sales and implementation services for this software product until it has been demonstrated at customer sites that the new release of the software is free of significant performance deficiencies. If we are not successful in
resolving these deficiencies on a timely basis, we may not be able to recognize this deferred revenue as we have projected.

OUR CASH POSITION HAS DECLINED
AND WILL LIKELY CONTINUE TO DECLINE UNTIL WE RETURN TO SUSTAINED PROFITABILITY

Our future long-term capital needs will depend significantly
on the rate of growth of our business, our profitability, the mix of subscription licensing arrangements versus perpetual licenses sold, possible acquisitions, the timing of expanded product offerings and the success of these offerings if and when
they are launched. Accordingly, our future long-term cash needs and cash flows are subject to substantial uncertainty. If our current balance of cash and cash equivalents is insufficient to satisfy our long-term liquidity needs, we may seek to sell
additional equity or debt securities to raise funds, and those future securities may have rights, preferences or privileges senior to those of the rights of our common stock. In connection with a sale of stock, our stockholders would experience
dilution. In addition, we cannot be certain that additional financing will be available to us on favorable terms when required, or at all.



28



---

##### Table of Contents

WE NEED TO GROW IN MARKETS OTHER THAN THE HEALTH AND LIFE SCIENCES MARKET FOR OUR FUTURE GROWTH

Our business plan has been to reduce our reliance on the health and life sciences market, which has traditionally been the primary source of our revenues,
by increasing sales in our Industry Solutions line of business, our non-health and life sciences business. Revenues from the Industry Solutions segment have comprised 24.4%, 26.0% and 23.6%, respectively, of our consolidated revenues for the years
ended December 31, 2005 and 2006 and three months ended March 31, 2007. We have not been successful in generating the revenue growth we expected from these markets and we cannot assure you that we will be successful in the future. One of
our key software products in the Industry Solutions segment has experienced certain deficiencies which we are working to resolve, and with respect to sales of which we have deferred revenue. See We cannot guarantee that our deferred revenue
will be recognized as planned.

WE MAY NOT BE SUCCESSFUL IN DEVELOPING OR ACQUIRING NEW TECHNOLOGIES OR BUSINESSES AND THIS COULD HINDER OUR
EXPANSION EFFORTS

Despite our intentions to reduce our product research and development efforts to levels more customary for our industry,
in the near term we may continue our product research and development efforts at levels similar to current expenditures. We have had quality issues with one of our software products, which have affected our sales and have caused us to defer revenue
recognition, and these issues may continue. We may consider additional acquisitions of or new investments in complementary businesses, products, services or technologies. We cannot assure you that we will be successful in our product development
efforts or that we will be able to identify appropriate acquisition or investment candidates. Even if we do identify suitable candidates, we cannot assure you that we will be able to make such acquisitions or investments on commercially acceptable
terms. Furthermore, we may incur debt or issue equity securities to pay for any future acquisitions. The issuance of equity securities could be dilutive to our existing stockholders and the issuance of debt could limit our available cash and
accordingly restrict our activities.

WE HAVE MANY COMPETITORS AND POTENTIAL COMPETITORS AND WE MAY NOT BE ABLE TO COMPETE EFFECTIVELY

The market for our products and services is competitive and subject to rapid change. We encounter significant competition for the sale of our contract
management software from the internal information systems departments of existing and potential clients, software companies that target the contract management markets and professional services organizations. Our competitors vary in size and in the
scope and breadth of products and services offered. We anticipate increased competition for market share and pressure to reduce prices and make sales concessions, particularly in our Industry Solutions segment, which could materially and adversely
affect our revenues and margins.

WE HAVE MULTIPLE FACILITIES AND WE MAY EXPERIENCE DIFFICULTIES IN OPERATING FROM THESE DIFFERENT LOCATIONS

We operate out of our corporate headquarters in Edison, New Jersey, engineering offices in Redwood City, California and Portland, Maine, and an office
facility in London, England. The geographic distance between our offices makes it more challenging for our management and other employees to collaborate and communicate with each other than if they were all located in a



29



---

##### Table of Contents

single facility, and, as a result, increases the strain on our managerial, operational and financial resources. Also, a significant number of our sales and
professional services employees work remotely out of home offices, which adds to this strain.

WE MAY NOT BE SUCCESSFUL IN RETAINING AND ATTRACTING
TALENTED AND KEY EMPLOYEES

We depend on the services of our senior management and key technical personnel. The loss of the services of key
employees, and the inability to attract new employees to fill crucial roles, could have a material adverse effect on our business, financial condition and results of operations.

OUR EFFORTS TO PROTECT OUR INTELLECTUAL PROPERTY MAY NOT BE FULLY EFFECTIVE, AND WE MAY INADVERTENTLY INFRINGE ON THE INTELLECTUAL PROPERTY OF OTHERS

Despite our efforts to protect our proprietary rights, unauthorized parties may attempt to copy aspects of our products or to obtain the use of
information that we regard as proprietary. In addition, the laws of some foreign countries do not protect our proprietary rights to as great an extent as do the laws of the United States. We cannot assure investors that our means of protecting our
proprietary rights will be adequate or that our competitors will not independently develop similar technology.

We are not aware that any
of our products infringe the proprietary rights of third parties. We cannot assure investors, however, that third parties will not claim infringement by us with respect to current or future products. We expect that software product developers will
increasingly be subject to infringement claims as the number of products and competitors in our industry segment grows and the functionality of products in different industry segments overlaps. Any such claims, with or without merit, could be
time-consuming, result in costly litigation, cause product shipment delays or require us to enter into royalty or licensing agreements. Such royalty or licensing agreements, if required, may not be available on terms acceptable to us or at all,
which could have a material adverse effect upon our business, operating results and financial condition.



|ITEM 2. | UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
|------- | -----------------------------------------------------------



|(b) | Use of Proceeds
|--- | ---------------

The Company has continued to use the
proceeds of its initial public offering in the manner and for the purposes described elsewhere in this Report on Form 10-Q.



|ITEM 6. | EXHIBITS
|------- | --------



|(a) | The exhibits listed on the Exhibit Index are filed herewith.
|--- | ------------------------------------------------------------



30



---

##### Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be
signed on its behalf by the undersigned thereunto duly authorized.



|                   |  |  |  |             |  |                                      
|------------------ |  |  |  | ----------- |  | -------------------------------------
|                   |  |  |  | I-MANY, INC
|                   |  |  | 
|Date: May 10, 2007 |  |  |  | By:         |  | /s/ Kevin M. Harris                  
|                   |  |  |  |             |  | Kevin M. Harris                      
|                   |  |  |  |             |  | Chief Financial Officer and Treasurer
|                   |  |  | 
|                   |  |  |  |             |  | /s/ Kevin M. Harris                  
|                   |  |  |  |             |  | Kevin M. Harris                      
|                   |  |  |  |             |  | Chief Financial Officer              



31



---

##### Table of Contents

INDEX TO EXHIBITS



|            |  |                                                                                                                                                                             
|----------- |  | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|EXHIBIT NO. |  | DESCRIPTION                                                                                                                                                                 
|            | 
|31.1        |  | Certification of Chief Executive Officer pursuant to Rules 13a-14(a) and 15d-14(a) of the Exchange Act, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|            | 
|31.2        |  | Certification of Chief Financial Officer pursuant to Rules 13a-14(a) and 15d-14(a) of the Exchange Act, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|            | 
|32.1        |  | Certifications pursuant to 18 U.S.C. sec. 1350.                                                                                                                             



32